Page last updated: 2024-08-25

tryptanthrine and Breast Neoplasms

tryptanthrine has been researched along with Breast Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Cho, J; Lai, D; Luo, C; Shen, X; Zeng, Q; Zhang, X; Zhou, W1
Chen, TM; Chen, YH; Chern, JW; Tseng, SY; Yu, ST1
Fang, JY; Fang, YP; Lin, YK; Su, YH1
Chen, TM; Chen, YH; Tseng, SY; Yu, ST1

Other Studies

4 other study(ies) available for tryptanthrine and Breast Neoplasms

ArticleYear
Tryptanthrin exerts anti-breast cancer effects both in vitro and in vivo through modulating the inflammatory tumor microenvironment.
    Acta pharmaceutica (Zagreb, Croatia), 2021, Jun-01, Volume: 71, Issue:2

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Quinazolines; Tumor Microenvironment

2021
Downregulation of GSTpi expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis.
    Anti-cancer drugs, 2009, Volume: 20, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Enzyme Induction; Female; Glutathione S-Transferase pi; Humans; JNK Mitogen-Activated Protein Kinases; Neoplasm Proteins; Phosphorylation; Protein Binding; Protein Processing, Post-Translational; Quinazolines

2009
Tryptanthrin-loaded nanoparticles for delivery into cultured human breast cancer cells, MCF7: the effects of solid lipid/liquid lipid ratios in the inner core.
    Chemical & pharmaceutical bulletin, 2011, Volume: 59, Issue:2

    Topics: Breast Neoplasms; Drug Delivery Systems; Female; Humans; Lipids; Nanoparticles; Quinazolines; Solubility; Tumor Cells, Cultured

2011
Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells.
    Biochemical and biophysical research communications, 2007, Jun-22, Volume: 358, Issue:1

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Mutation; Promoter Regions, Genetic; Quinazolines; Tumor Suppressor Protein p53

2007